Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax Provisions
Others
Ratios

Tango Therapeutics (TNGX) Shares Outstanding (Diluted Average): 2021-2024

Historic Shares Outstanding (Diluted Average) for Tango Therapeutics (TNGX) over the last 4 years, with Dec 2024 value amounting to $109.2 million.

  • Tango Therapeutics' Shares Outstanding (Diluted Average) rose 1.70% to $110.5 million in Q2 2025 from the same period last year, while for Jun 2025 it was $110.5 million, marking a year-over-year increase of 1.70%. This contributed to the annual value of $109.2 million for FY2024, which is 15.50% up from last year.
  • As of FY2024, Tango Therapeutics' Shares Outstanding (Diluted Average) stood at $109.2 million, which was up 15.50% from $94.6 million recorded in FY2023.
  • Over the past 5 years, Tango Therapeutics' Shares Outstanding (Diluted Average) peaked at $109.2 million during FY2024, and registered a low of $62.1 million during FY2021.
  • Its 3-year average for Shares Outstanding (Diluted Average) is $97.2 million, with a median of $94.6 million in 2023.
  • Data for Tango Therapeutics' Shares Outstanding (Diluted Average) shows a peak YoY skyrocketed of 41.40% (in 2022) over the last 5 years.
  • Tango Therapeutics' Shares Outstanding (Diluted Average) (Yearly) stood at $62.1 million in 2021, then skyrocketed by 41.40% to $87.8 million in 2022, then climbed by 7.69% to $94.6 million in 2023, then grew by 15.50% to $109.2 million in 2024.